Emollients for prevention of atopic dermatitis in infancy
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Atopic dermatitis (also known as eczema and atopic eczema) is the most common chronic inflammatory disorder of the skin and affects around a quarter of children.1 Worldwide, its prevalence is increasing2 and persistence into adulthood is common.3 The first manifestations usually appear in early life with dry, cracked, scaly, and erythematous skin, and at all ages intractable pruritus. Atopic dermatitis can result in impaired quality of life for individuals and their families, alongside considerable social and financial burden.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“After initial promising results using such emollients and moisturizers in the prevention of AD in newborns at high risk48,49, a more recent report has questioned this strategy50,51.”
From Atopic dermatitis: an expanding therapeutic pipeline for a complex disease (2022) · cites this paper as [50]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Kelleher, M., Dunn-Galvin, A., Hourihane, J. O., Murray, D., Campbell, L. E., McLean, W. H. I., & Irvine, A. D. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.12.013 · Cited by 225
RetractedAsher, M. I., Montefort, S., Björkstén, B., Lai, C. K., Strachan, D. P., Weiland, S. K., & Williams, H. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69283-0 · Cited by 4,223
Filaggrin Mutations Associated with Skin and Allergic Diseases
Irvine, A. D., McLean, W. H. I., & Leung, D. Y. M. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1011040 · Cited by 1,217
Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three
Odhiambo, J. A., Williams, H. C., Clayton, T. O., Robertson, C. F., & Asher, M. I. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.10.009 · Cited by 966
Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention
Simpson, E. L., Chalmers, J. R., Hanifin, J. M., Thomas, K. S., Cork, M. J., McLean, W. H. I., Brown, S. J., Chen, Z., Chen, Y., & Williams, H. C. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.08.005 · Cited by 722
The burden of atopic dermatitis: summary of a report for the National Eczema Association.
Drucker, A. M., Wang, A. R., Li, W.-Q., Sevetson, E., Block, J. K., & Qureshi, A. A. (2017) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.07.012 · Cited by 720
Application of moisturizer to neonates prevents development of atopic dermatitis
Horimukai, K., Morita, K., Narita, M., Kondo, M., Kitazawa, H., Nozaki, M., Shigematsu, Y., Yoshida, K., Niizeki, H., Motomura, K.-I., et al. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.07.060 · Cited by 607
Loss-of-function variants in the filaggrin gene are a significant risk factor for peanut allergy
Brown, S. J., Asai, Y., Cordell, H. J., Campbell, L. E., Zhao, Y., Liao, H., Northstone, K., Henderson, J., Alizadehfar, R., Ben-Shoshan, M., et al. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.01.031 · Cited by 477
Daily emollient during infancy for prevention of eczema: the BEEP randomised controlled trial
Chalmers, J. R., Haines, R. H., Bradshaw, L. E., Montgomery, A. A., Thomas, K. S., Brown, S. J., Ridd, M. J., Lawton, S., Simpson, E. L., Cork, M. J., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(19)32984-8 · Cited by 317
Skjerven, H. O., Rehbinder, E. M., Vettukattil, R., LeBlanc, M., Granum, B., Haugen, G., Hedlin, G., Landrø, L., Marsland, B. J., Rudi, K., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(19)32983-6 · Cited by 234
Cited by
Atopic dermatitis: an expanding therapeutic pipeline for a complex disease
Bieber, T. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00266-6 · Cited by 623
The infectious complications of atopic dermatitis
Wang, V., Boguniewicz, J., Boguniewicz, M., & Ong, P. Y. (2021) · Annals of Allergy, Asthma & Immunology · doi:10.1016/j.anai.2020.08.002 · Cited by 185
Skjerven, H. O., Lie, A., Vettukattil, R., Rehbinder, E. M., LeBlanc, M., Asarnoj, A., Carlsen, K.-H., Despriee, Å. W., Färdig, M., Gerdin, S. W., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(22)00687-0 · Cited by 182
Disease modification in inflammatory skin disorders: opportunities and challenges
Bieber, T. R. M. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00735-0 · Cited by 141
Demessant‐Flavigny, A., Connétable, S., Kérob, D., Moreau, M., Aguilar, L., & Wollenberg, A. (2023) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.19125 · Cited by 111
Metadata
- Authors
- Perrett, K. P., & Peters, R. L.
- Affiliations
- Royal Children's Hospital (AU)
- The University of Melbourne (AU)
- Corresponding author
- Perrett, Kirsten P
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2020-03
- Volume
- 395
- Issue
- 10228
- Pages
- 923-924
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W3006923018
- Cited by
- 43
- References
- 14
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 6 · 2023: 9 · 2022: 10 · 2021: 10 · 2020: 4
- FWCI
- 5.94
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
- Locations
- The Lancet (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by-nc-nd)
- Funders
- Wellcome Trust (106865/Z/15/Z)
- Topics
- Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Neonatal skin health care
- Health Sciences › Medicine › Dermatology › Contact Dermatitis and Allergies
- Keywords
- atopic dermatitis, emollients, prevention, infancy, pruritus, skin barrier, pediatric dermatology
- MeSH terms
- Dermatitis, Atopic, Eczema, Emollients, Humans, Infant, Infant Nutritional Physiological Phenomena, Skin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Emollients for prevention of atopic dermatitis in infancy. https://app.cochat.ai/papers/10.1016/s0140-6736(19)33174-5
- The paper
- Perrett, K. P., & Peters, R. L. (2020). Emollients for prevention of atopic dermatitis in infancy. The Lancet. https://doi.org/10.1016/s0140-6736(19)33174-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
